Interestingly and particularly in cancer, IGF-I splice variants appear to be sensitive to the specific cancer type and the state of the disease, showing a differential regulation of specific isoform(s) (Armakolas et al., 2010; Koczorowska et al., 2011; Kasprzak et al., 2012). This evidence concerns the gene IGF1 and cancer.